Morepen Laboratories Limited issued a revised press release regarding its quarterly performance, correcting the financial year mentioned in the original document. The company reported a significant increase in quarterly revenue and profits, with medical device sales experiencing remarkable growth. Profit before tax doubled compared to the previous quarter, reflecting strong operational performance. The press release highlights the company's achievements and ongoing projects, including a partnership for vaccine production.
This is in reference to the Press Release submitted with your good office, we would like to mention that, inadvertently, the financial year was mentioned as FY 2020-22 instead of FY 2021-22. All other information remains unchanged. The revised press release is enclosed herewith.